This study was conducted on 72 American Society of Anesthesiologists class 1 patients scheduled for extraction of a mandibular third molar after inferior alveolar nerve block. Each patient was randomly administered one of the following ropivacaine concentrations: 0.75%, 0.5%, 0.375%, or 0.25% (18 patients per group). Onset of block (mean ± SD) was rapid for both 0.75% (1.4 ± 0.4 minutes) and 0.5% (1.7 ± 0.5 minutes) ropivacaine but significantly slower for the 0.375% (4.2 ± 2.5 minutes) and 0.25% (10.7 ± 3.0 minutes) concentrations. Tooth extraction was performed successfully with the 0.5% and 0.75% concentrations, and supplemental injections were not required. Second injections, however, were required with 0.375% ropivacaine. Anesthesia was unsuccessful in 13 patients given 0.25% ropivacaine even after 3 injections. The mean durations of soft tissue anesthesia were 3.3 ± 0.3 hours and 3.0 ± 0.3 hours for the 0.75% and 0.5% concentrations, but significantly shorter with more dilute concentrations. The duration of analgesia showed a similar pattern, with the 0.75% and 0.5% concentrations producing prolonged analgesia of 6.0 ± 0.4 hours and 5.6 ± 0.4 hours. These results indicate that 0.5% and 0.75% concentrations were effective for intraoral nerve blockade, with both a rapid onset and prolonged duration of pain control.
Mean onset time of anesthesia after ropivacaine nerve block (18 patients per group; each bracket indicates the standard deviation). *P < .001 compared with 0.25% ropivacaine; †P < .001 compared with 0.375% ropivacaine; and ‡ P < .05 compared with 0.5% ropivacaine.
Figure 2.
Mean quality of anesthesia during surgery (18 patients per group; each bracket indicates the standard deviation). Rating scores are defined in Table 1. *P < .001 compared with 0.25% ropivacaine; †P < .001 compared with 0.375% ropivacaine.
Figure 3.
Mean duration of lip tissue anesthesia after ropivacaine nerve block (18 patients per group; each bracket indicates the standard deviation). *P < .001 compared with 0.25% ropivacaine; †P < .001 compared with 0.375% ropivacaine; and ‡P < .01 compared with 0.5% ropivacaine.
Figure 4.
Mean duration of analgesia after ropivacaine nerve block (18 patients per group; each bracket indicates the standard deviation). *P < .001 compared with 0.25% ropivacaine; †P < .001 compared with 0.375% ropivacaine; and ‡P < .01 compared with 0.5% ropivacaine.
Contributor Notes
Address correspondence to Dr John A. Yagiela, UCLA School of Dentistry, Center for the Health Sciences, Los Angeles, CA 90095-1668; johny@dent.ucla.edu.